Mutant p53 R175H promotes cancer initiation in the pancreas by stabilizing HSP70

Kishore Polireddy, Kanchan Singh, Melissa Pruski, Neal C. Jones, Naveen V. Manisundaram, Pavani Ponnela, Michel Ouellette, George Van Buren, Mamoun Younes, John S. Bynon, Wasim A. Dar, Jennifer M. Bailey

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Pancreatic cancer remains a highly lethal malignancy. We have recently shown that simultaneous expression of Kras and mutant Tp53 R175H promotes invasive ductal adenocarcinoma from pancreatic ductal cells. We hypothesized specific mutations in TP53 have divergent mechanisms of transforming ductal cells. In order to understand the role of mutant TP53 in transforming pancreatic ductal cells, we used a lentiviral system to express mutant TP53 R175H and TP53 R273H , two of the most frequently mutated TP53 alleles in pancreatic cancer patients, in immortalized, but not transformed, pancreatic ductal epithelial cells carrying a KRAS mutation (HPNE:KRAS G12D ). Mutant TP53 expression enhanced colony formation and an RPPA assay results revealed TP53 R175H uniquely induced HSP70 expression in HPNE:KRAS G12D cells. In the context of TP53 R175H expression; we observed nuclear localization of HSP70. We performed immunoprecipitation experiments to show mutant p53 R175H binds to HSP70. We also provide evidence mutant p53 R175H is important for HSP70 stability and, more importantly, HSP70 is required for mutant p53 stability. These data are critical in the context of events leading to cellular transformation in the pancreas.

Original languageEnglish (US)
Pages (from-to)122-130
Number of pages9
JournalCancer Letters
Volume453
DOIs
StatePublished - Jul 1 2019

Fingerprint

Pancreas
Pancreatic Neoplasms
Neoplasms
Mutation
Immunoprecipitation
Adenocarcinoma
Epithelial Cells
Alleles

Keywords

  • Pancreatic cancer
  • Proteomics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Polireddy, K., Singh, K., Pruski, M., Jones, N. C., Manisundaram, N. V., Ponnela, P., ... Bailey, J. M. (2019). Mutant p53 R175H promotes cancer initiation in the pancreas by stabilizing HSP70 Cancer Letters, 453, 122-130. https://doi.org/10.1016/j.canlet.2019.03.047

Mutant p53 R175H promotes cancer initiation in the pancreas by stabilizing HSP70 . / Polireddy, Kishore; Singh, Kanchan; Pruski, Melissa; Jones, Neal C.; Manisundaram, Naveen V.; Ponnela, Pavani; Ouellette, Michel; Van Buren, George; Younes, Mamoun; Bynon, John S.; Dar, Wasim A.; Bailey, Jennifer M.

In: Cancer Letters, Vol. 453, 01.07.2019, p. 122-130.

Research output: Contribution to journalArticle

Polireddy, K, Singh, K, Pruski, M, Jones, NC, Manisundaram, NV, Ponnela, P, Ouellette, M, Van Buren, G, Younes, M, Bynon, JS, Dar, WA & Bailey, JM 2019, ' Mutant p53 R175H promotes cancer initiation in the pancreas by stabilizing HSP70 ', Cancer Letters, vol. 453, pp. 122-130. https://doi.org/10.1016/j.canlet.2019.03.047
Polireddy K, Singh K, Pruski M, Jones NC, Manisundaram NV, Ponnela P et al. Mutant p53 R175H promotes cancer initiation in the pancreas by stabilizing HSP70 Cancer Letters. 2019 Jul 1;453:122-130. https://doi.org/10.1016/j.canlet.2019.03.047
Polireddy, Kishore ; Singh, Kanchan ; Pruski, Melissa ; Jones, Neal C. ; Manisundaram, Naveen V. ; Ponnela, Pavani ; Ouellette, Michel ; Van Buren, George ; Younes, Mamoun ; Bynon, John S. ; Dar, Wasim A. ; Bailey, Jennifer M. / Mutant p53 R175H promotes cancer initiation in the pancreas by stabilizing HSP70 In: Cancer Letters. 2019 ; Vol. 453. pp. 122-130.
@article{b4fb824073ad4e4ab5faf974bb733aa4,
title = "Mutant p53 R175H promotes cancer initiation in the pancreas by stabilizing HSP70",
abstract = "Pancreatic cancer remains a highly lethal malignancy. We have recently shown that simultaneous expression of Kras and mutant Tp53 R175H promotes invasive ductal adenocarcinoma from pancreatic ductal cells. We hypothesized specific mutations in TP53 have divergent mechanisms of transforming ductal cells. In order to understand the role of mutant TP53 in transforming pancreatic ductal cells, we used a lentiviral system to express mutant TP53 R175H and TP53 R273H , two of the most frequently mutated TP53 alleles in pancreatic cancer patients, in immortalized, but not transformed, pancreatic ductal epithelial cells carrying a KRAS mutation (HPNE:KRAS G12D ). Mutant TP53 expression enhanced colony formation and an RPPA assay results revealed TP53 R175H uniquely induced HSP70 expression in HPNE:KRAS G12D cells. In the context of TP53 R175H expression; we observed nuclear localization of HSP70. We performed immunoprecipitation experiments to show mutant p53 R175H binds to HSP70. We also provide evidence mutant p53 R175H is important for HSP70 stability and, more importantly, HSP70 is required for mutant p53 stability. These data are critical in the context of events leading to cellular transformation in the pancreas.",
keywords = "Pancreatic cancer, Proteomics",
author = "Kishore Polireddy and Kanchan Singh and Melissa Pruski and Jones, {Neal C.} and Manisundaram, {Naveen V.} and Pavani Ponnela and Michel Ouellette and {Van Buren}, George and Mamoun Younes and Bynon, {John S.} and Dar, {Wasim A.} and Bailey, {Jennifer M.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.canlet.2019.03.047",
language = "English (US)",
volume = "453",
pages = "122--130",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Mutant p53 R175H promotes cancer initiation in the pancreas by stabilizing HSP70

AU - Polireddy, Kishore

AU - Singh, Kanchan

AU - Pruski, Melissa

AU - Jones, Neal C.

AU - Manisundaram, Naveen V.

AU - Ponnela, Pavani

AU - Ouellette, Michel

AU - Van Buren, George

AU - Younes, Mamoun

AU - Bynon, John S.

AU - Dar, Wasim A.

AU - Bailey, Jennifer M.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Pancreatic cancer remains a highly lethal malignancy. We have recently shown that simultaneous expression of Kras and mutant Tp53 R175H promotes invasive ductal adenocarcinoma from pancreatic ductal cells. We hypothesized specific mutations in TP53 have divergent mechanisms of transforming ductal cells. In order to understand the role of mutant TP53 in transforming pancreatic ductal cells, we used a lentiviral system to express mutant TP53 R175H and TP53 R273H , two of the most frequently mutated TP53 alleles in pancreatic cancer patients, in immortalized, but not transformed, pancreatic ductal epithelial cells carrying a KRAS mutation (HPNE:KRAS G12D ). Mutant TP53 expression enhanced colony formation and an RPPA assay results revealed TP53 R175H uniquely induced HSP70 expression in HPNE:KRAS G12D cells. In the context of TP53 R175H expression; we observed nuclear localization of HSP70. We performed immunoprecipitation experiments to show mutant p53 R175H binds to HSP70. We also provide evidence mutant p53 R175H is important for HSP70 stability and, more importantly, HSP70 is required for mutant p53 stability. These data are critical in the context of events leading to cellular transformation in the pancreas.

AB - Pancreatic cancer remains a highly lethal malignancy. We have recently shown that simultaneous expression of Kras and mutant Tp53 R175H promotes invasive ductal adenocarcinoma from pancreatic ductal cells. We hypothesized specific mutations in TP53 have divergent mechanisms of transforming ductal cells. In order to understand the role of mutant TP53 in transforming pancreatic ductal cells, we used a lentiviral system to express mutant TP53 R175H and TP53 R273H , two of the most frequently mutated TP53 alleles in pancreatic cancer patients, in immortalized, but not transformed, pancreatic ductal epithelial cells carrying a KRAS mutation (HPNE:KRAS G12D ). Mutant TP53 expression enhanced colony formation and an RPPA assay results revealed TP53 R175H uniquely induced HSP70 expression in HPNE:KRAS G12D cells. In the context of TP53 R175H expression; we observed nuclear localization of HSP70. We performed immunoprecipitation experiments to show mutant p53 R175H binds to HSP70. We also provide evidence mutant p53 R175H is important for HSP70 stability and, more importantly, HSP70 is required for mutant p53 stability. These data are critical in the context of events leading to cellular transformation in the pancreas.

KW - Pancreatic cancer

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=85063864674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063864674&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2019.03.047

DO - 10.1016/j.canlet.2019.03.047

M3 - Article

C2 - 30946870

AN - SCOPUS:85063864674

VL - 453

SP - 122

EP - 130

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

ER -